Serum APRIL was significantly upregulated in RA patients compared to healthy controls (P < 0.0001) with mean ± SD = 7.39 ± 1.2 vs 2.3 ± 0.069 ng/ml, respectively (Fig. 1a). Here, TNFSF13 is linked to rheumatoid arthritis.